Kocitaf 50mg/200mg/25mg Tablet is unsafe to work with in sufferers with liver illness and may be prevented.This groundbreaking drug is generally being explored for its prospective position in oncology, particularly targeting various different types of cancer. Scientists can also be investigating its application in autoimmune health conditions, aimi